Skip to content

Lung Cancer Blog

Everything about lung cancer is here.

Menu
  • Home
  • About Us
  • Lung Cancer
    • Lung Cancer News
    • Causes of Lung Cancer
    • Lung Cancer Symptoms
    • Types of Lung Cancer
    • Stages of Lung Cancer
    • Lung Cancer Treatment
    • Lung Cancer Drugs
    • Lung Cancer In Ayurveda
    • Chinese Herbs For Lung Cancer
  • Researches
  • Studies
  • Stories
  • Sitemap
  • Contact Us
Menu
SCLC, Small Cell Lung Cancer

Personalized Treatment for Small Cell Lung Cancer, MedUni Vienna Study Suggests

Posted on October 17, 2022
Post Views: 338

SCLC, Small Cell Lung CancerThere are two main types of lung cancer: small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). SCLC is a particularly aggressive form of tumor and is mainly treated with standardized measures. About 10% to 15% of all lung cancers are SCLC and this type of cancer tends to grow and spread at faster rate than NSCLC. In most of the cases, it is diagnosed when cancer has already spread. A study has been conducted by MedUni Vienna in Austria that has shown for the first time that different subtypes of SCLC have specific molecular characteristics and thus, the patients respond differently to cancer treatment.

The study findings were published in the journal Clinical and Translational Medicine. It has opened up new opportunities for development of personalized treatment for SCLC. The study has shown for the first time that different SCLC subtypes have specific molecular characteristics and thus, those affected respond in different ways to treatment of lung cancer. The researchers from Austria, Hungary, Brazil, Sweden and the Netherlands are highlighting that single treatment is not that effective and the treatment approaches should be tailored according to the specific molecular characteristics of the respective subtypes.

The scientists have analyzed the entire protein composition of human SCLC cell lines. They used their selected proteomic approach combined with bioinformatic analyses to achieve large-scale identification and qualification of proteins. This in turn, helps in determination of specific molecular signatures for each subtype. Study co-leader Karin Schelch from MedUni Vienna’s Department of Thoracic Surgery said, “The analytical approach we chose enabled us to quantify more than 10,000 proteins, several of which proved to be specific to a particular subtype.” “These subtype-specific proteins provide an excellent basis for the development of targeted SCLC treatment.” As conventional treatment for SCLC has reached its efficacy plateau, new personalized treatments are required for the purpose of improving lung cancer survival rates.

The information shared in this blog is for educational purposes only. You should consult your healthcare professional for any medical needs.

Subscribe to our newsletter or follow us on Twitter or Facebook today and never miss an update!

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • Click to share on Pinterest (Opens in new window) Pinterest
  • Click to share on Threads (Opens in new window) Threads
  • Click to share on WhatsApp (Opens in new window) WhatsApp
  • Click to share on Reddit (Opens in new window) Reddit
  • Click to share on Tumblr (Opens in new window) Tumblr
  • Click to share on Pocket (Opens in new window) Pocket
  • Click to share on Telegram (Opens in new window) Telegram

Like this:

Like Loading...

Subscribe Us

Popular Articles

  • Lung Cancer Treatment in Ayurveda (7,324)
  • Lung Cancer: Symptoms and Treatment (5,655)
  • What is Non-Small-Cell Lung Cancer? (5,551)

Recent Comments

  • Lung Cancer on New Study To Help Advance Research In Lung Cancer
  • Laurie B Grimes on New Study To Help Advance Research In Lung Cancer
  • Lung Cancer on Asbestos and Lung Cancer – What’s The Link?

Recent Articles

  • Study: Wildfire Smoke Exposure Affects Lung Cancer Survival June 2, 2025
  • Predicting Lung Cancer Risk with AI based Deep Learning Model May 26, 2025
  • FDA Grants Accelerated Approval to Telisotuzumab Vedotin-tllv for NSCLC May 19, 2025
  • Heart-Sparing Technique in Lung Cancer Radiotherapy May 12, 2025
  • Origins of Common Lung Cancer Linked to Smoking Discovered May 5, 2025

Lung Cancer Blog

Lung Cancer Blog provides all lung cancer related information for educational purposes.

Disclaimer

Some post may contain affiliate links, purchasing that product not going to cost extra but by your purchase Lung Cancer will get some little commission and that amount will help in surviving this website. So, please don’t hesitate to buy from these affiliate links.

Contact Us

If you have any query or suggestions about our blog, please feel free to email us at  lungcancersymptomsx@gmail.com.

Copyright © 2012 - 2025 Lung Cancer Blog. Wordpress by Vipasha.
  • Privacy Policy
  • About Us
  • Sitemap
  • Contact Us
%d